121 related articles for article (PubMed ID: 9225303)
1. Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism.
Rizzi CA; Mierau J; Ladinsky H
Neuropharmacology; 1997 Jun; 36(6):763-8. PubMed ID: 9225303
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoclopramide and tropisetron on aldosterone secretion possibly due to agonism and antagonism at the 5-HT4 receptor.
Sommers DK; Snyman JR; van Wyk M
Eur J Clin Pharmacol; 1996; 50(5):371-3. PubMed ID: 8839658
[TBL] [Abstract][Full Text] [Related]
3. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man.
Farrow S; Mahayni A; Banta G; Sowers J; Lockette W
Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
[TBL] [Abstract][Full Text] [Related]
7. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
Sowers JR; Eggena P; Phillips D
Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
[TBL] [Abstract][Full Text] [Related]
8. Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.
Sommers DK; Snyman JR; van Wyk M
Eur J Clin Pharmacol; 1993; 44(4):337-9. PubMed ID: 8390368
[TBL] [Abstract][Full Text] [Related]
9. Effect of saline load and metoclopramide on the renal dopaminergic system in patients with heart failure and healthy controls.
Alvelos M; Ferreira A; Bettencourt P; Pimenta J; Azevedo A; Serrão P; Rocha-Gonçalves F; Soares-da-Silva P
J Cardiovasc Pharmacol; 2005 Mar; 45(3):197-203. PubMed ID: 15725943
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the central effects of dopamine and metoclopramide on aldosterone regulation in the rat.
Kawabe H; Kondo K; Hayashi M; Fujimaki M; Nagahama S; Saruta T
Endocrinol Jpn; 1983 Aug; 30(4):543-9. PubMed ID: 6323152
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
Sowers JR; Berg G; Martin VS; Mayes DM
Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
[TBL] [Abstract][Full Text] [Related]
13. Metoclopramide and domperidone block the antihypertensive effect of bromocriptine in hypertensive patients.
Luchsinger A; Grilli M; Velasco M
Am J Ther; 1998 Mar; 5(2):81-8. PubMed ID: 10099042
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans.
Blumberg AL; Dubb JW; Allison NL; Aldins Z; Ramey K; Stote RM
J Cardiovasc Pharmacol; 1988 Feb; 11(2):181-6. PubMed ID: 2452312
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic control of renal tubular function in patients with compensated cirrhosis.
Sansoè G; Ferrari A; Baraldi E; Castellana CN; Biava A; Silvano S; Rosina F; Bonardi L; Manenti F
Dig Dis Sci; 2002 Feb; 47(2):392-400. PubMed ID: 11855557
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro studies on the effect of metoclopramide on aldosterone secretion.
Edwards CR; Al-Dujaili EA; Boscaro M; Quyyumi S; Miall PA; Rees LH
Clin Endocrinol (Oxf); 1980 Jul; 13(1):45-50. PubMed ID: 7438463
[TBL] [Abstract][Full Text] [Related]
17. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
Stern N; Eggena P; Chandler W; Tuck ML
Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
[TBL] [Abstract][Full Text] [Related]
18. Effects of enhancement and antagonism of 5-hydroxytryptamine activity on metoclopramide-induced aldosterone secretion in man.
Sommers DK; Meyer EC; van Wyk M
Res Exp Med (Berl); 1991; 191(6):423-7. PubMed ID: 1775733
[TBL] [Abstract][Full Text] [Related]
19. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion.
Brown RD; Billman GE; Kem DC; Stone HL; Jiang NS; Kao P; Hegstad RL
J Clin Endocrinol Metab; 1982 Nov; 55(5):828-32. PubMed ID: 7119085
[TBL] [Abstract][Full Text] [Related]
20. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
Sowers JR
Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
